Stay updated on Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial
Sign up to get notified when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.

Latest updates to the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe completed Phase 3 study record for daxibotulinumtoxinA is displayed, including its design, outcomes, eligibility criteria, locations, and study documents.SummaryDifference49%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the existing 403 error page.SummaryDifference1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe 403 error content was removed, restoring access to the study details view for the trial. Users can now view the page content.SummaryDifference0.5%

Stay in the know with updates to Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.